Correction to “Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease”

Key Points

• This correction addresses previous findings on the relationship between plasma phosphorylated tau217 and cognitive impairment as well as brain alterations in Alzheimer's disease.
• Correction to previously published data regarding plasma phosphorylated tau217 measurements.
• Review of cognitive assessments and brain imaging related to Alzheimer's disease.
• Clarified associations of elevated plasma phosphorylated tau217 with increased cognitive impairment in Alzheimer's disease.
• Revised microstructural alteration data in relation to cognitive outcomes.